Contemporary research has unveiled that the prevalence of EVA1A protein expression in T3/T4 stage esophageal squamous cell carcinoma stands at a substantial 77.8% (21/27), markedly surpassing that in the T1/T2 stage (41.7%, 5/12). The gene discussed is EVA1A; the disease is esophageal squamous cell carcinoma.